ASTELLAS DOSES FIRST PATIENT IN PHASE 3 STUDY OF ASP2138 IN CLDN18.2-POSTIVE AND HER2-NEGATIVE LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC OR GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA

Reuters · 2d ago

Please log in to view news